![]() |
市场调查报告书
商品编码
1764952
北美外周栓塞线圈市场预测(至2031年)-区域分析(按类型、材料和应用)North America Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application |
2023 年北美週边栓塞线圈市场价值为 2.4786 亿美元,预计到 2031 年将达到 3.6053 亿美元;预计 2023 年至 2031 年的复合年增长率为 4.8%。
主动脉瘤丢失盛行率上升推动北美週边栓塞线圈市场
主动脉瘤是人体主要动脉或主动脉的膨出壁。根据美国心臟协会 2023 年的资料,2020 年全球报告的死亡人数为 15 万人,比 2010 年增加了 26%。吸烟者和女性的动脉瘤破裂率较高。目前,尚无有效药物可预防主动脉瘤的发展;唯一的治疗方法是手术或血管内修復。栓塞剂通常用作开放性手术的替代品,而开放性手术风险更高,恢復期也更长。週边血管栓塞线圈、氰基丙烯酸酯或纤维蛋白胶、凝胶泡沫和 Onyx 是常用于治疗主动脉瘤内漏的栓塞装置。栓塞术是治疗週边动脉瘤的理想选择,因为它比开放性手术修復的创伤更小。此外,栓塞术也可用于选择性治疗某些先天性心臟病、瘻管、动脉瘤以及冠状动脉绕道术后的动脉侧支盗血症候群。因此,主动脉瘤盛行率的上升推动了周边栓塞栓塞术市场的成长。
北美週边栓塞线圈市场概况
基于美国、加拿大和墨西哥的市场状况,本文对北美週边栓塞线圈市场进行了分析。大肠直肠癌和创伤盛行率的激增是推动该地区市场成长的主要因素。大肠直肠癌是墨西哥第四大常见癌症,大多数病例发生在50岁以后,男女病例分布相似。因此,随着预期寿命的延长,新病例数和死亡率也稳定上升。由于週边动脉疾病(PAD)和动脉瘤等血管疾病的盛行率不断上升,需要微创治疗方案,美国週边栓塞线圈市场正在经历成长。週边栓塞线圈对于血管内栓塞至关重要,可以防止出血或减少目标区域的血流量。随着医疗保健提供者专注于透过微创手术改善患者预后,对这些线圈的需求正在上升。技术进步,例如更有效率和生物相容性的线圈的开发,以及人们对血管内治疗的认识不断提高,正在进一步推动美国市场的扩张。
墨西哥的癌症发生率正在上升,大肠直肠癌位列第三大常见癌症。根据IMSS的数据,该国每年约有1.5万例结肠癌新病例。预计墨西哥的结直肠癌市场将持续成长,以推动癌症早期发现运动。根据GLOBOCAN的数据,2020年墨西哥的胃癌发生率为6.2%,死亡率为每十万人4.7人。微线圈栓塞术是一种成熟的上消化道出血治疗方法,可在更靠近出血部位的位置进行。使用超选择性导管进行的手术是治疗急性下消化道出血的安全有效的方法。根据Statista的数据,2021年加拿大每10万例住院病例中约有600例是因创伤住院。根据《加拿大外科杂誌》(CJS)2021年发表的一篇文章,经动脉栓塞术已成功用于治疗非脾臟创伤;最常见的栓塞技术是使用凝胶泡沫栓塞。这些手术成功率高,併发症发生率低。此外,加拿大卫生部已批准多种用于治疗颅内动脉瘤的弹簧圈和弹簧圈输送系统。弹簧圈栓塞术可与其他辅助血管内装置(如支架和球囊)搭配使用。
北美週边栓塞线圈市场收入及预测(2031 年)(百万美元)
北美週边栓塞线圈市场细分
北美外周栓塞线圈市场按类型、材料、应用和国家分类。
根据类型,北美外周栓塞线圈市场分为可分离线圈和可推动线圈。 2023年,可分离线圈占据了较大的市占率。
就材质而言,北美週边栓塞线圈市场分为铂金、铂金水凝胶以及铂钨合金。铂金在2023年占据了最大的市场份额。
根据应用,北美週边栓塞线圈市场细分为出血和创伤、畸形、肿瘤、内臟动脉瘤、II型内漏和静脉曲张。出血和创伤领域在2023年占据了最大的市场。
根据国家/地区,北美週边栓塞线圈市场分为美国、加拿大和墨西哥。 2023年,美国占据了北美週边栓塞线圈市场的主导地位。
Medtronic Plc、Penumbra, Inc.、Balt、Boston Scientific Corp、Cook Medical Holdings LLC、Wallaby Medical、Spartan Micro Inc. 和 Terumo Corp. 是北美外周栓塞线圈市场的一些领先公司。
The North America peripheral embolization coils market was valued at US$ 247.86 million in 2023 and is expected to reach US$ 360.53 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.
Rise in Prevalence of Aortic Aneurysm Loss Fuels North America Peripheral Embolization Coils Market
An aortic aneurysm is a bulging wall of the body's major artery or aorta. According to the American Heart Association's 2023 data, aortic aneurysms were the cause of 150,000 fatalities reported across the world in 2020, indicating a 26% rise from 2010. Smokers and women had greater rates of aneurysmal rupture. Currently, there are no effective medications to prevent the development of aortic aneurysms; the only treatment options are surgical or endovascular repair. Embolization agents are frequently used as substitutes for open surgeries, which are riskier and followed by longer recovery periods. Peripheral vascular embolization coils, cyanoacrylate or fibrin glue, gel foam, and Onyx are among the embolic devices that are commonly used to treat endoleaks from aortic aneurysms. Coiling is a suitable therapy option for peripheral aneurysms since it is less invasive than open surgical repair. Coils can also be used in elective settings to treat some congenital cardiac diseases, fistulas, aneurysms, and arterial side branch steal syndrome after coronary artery bypass grafting. Therefore, an upsurge in the prevalence of aortic aneurysms drives the growth of the peripheral embolization coils market.
North America Peripheral Embolization Coils Market Overview
The peripheral embolization coils market in North America has been analyzed based on the market scenarios in United States, Canada and Mexico. An upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. Colorectal cancer is the fourth most prevalent cancer in Mexico, with most cases reported after the age of 50, with a comparable distribution of cases in both genders. As a result, the number of new cases and rate of mortality have steadily climbed alongside the rising life expectancy. The peripheral embolization coil market in the United States is experiencing growth due to the increasing prevalence of vascular diseases, such as peripheral artery disease (PAD) and aneurysms, requiring minimally invasive treatment options. Peripheral embolization coils are essential for including blood vessels to prevent hemorrhage or reduce blood flow in targeted areas. As healthcare providers focus on improving patient outcomes with less invasive procedures, the demand for these coils is rising. Technological advancements, such as the development of more efficient and biocompatible coils, along with growing awareness of endovascular treatments, are further driving market expansion in the United States.
Cancer incidences are rising in Mexico, and colorectal cancer is ranked as the third most frequently diagnosed cancer. According to IMSS, every year approximately 15,000 new cases are registered with colon cancer in the country. The market for colorectal cancer in Mexico is expected to grow to increase the campaign for early detection of cancers. According to GLOBOCAN, in Mexico, the incidence rate of gastric cancer was 6.2% in 2020, with a mortality rate of 4.7 per 100,000 persons. Microcoil embolization is a well-established treatment for upper gastrointestinal bleeding that can be performed closer to the bleeding site. The procedure performed using a superselective catheter is a safe and effective way of managing acute lower gastrointestinal bleeding. According to Statista, trauma was the reason for ~600 per 100,000 hospitalizations in Canada in 2021. According to an article published by the Canadian Journal of Surgery (CJS) in 2021, transarterial embolization procedures are successfully being used to treat non-splenic traumatic injuries; the most common embolization technique is coiling with gel foam. These procedures have high success rates with low rates of complications. Moreover, Health Canada has approved numerous coils and coil delivery systems for the treatment of intracranial aneurysms. Coil embolization is used with other adjunct endovascular devices, such as stents and balloons.
North America Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)
North America Peripheral Embolization Coils Market Segmentation
The North America peripheral embolization coils market is categorized into type, material, application, and country.
Based on type, the North America peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.
In terms of material, the North America peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.
By application, the North America peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.
Based on country, the North America peripheral embolization coils market is segmented into the US, Canada, and Mexico. The US dominated the North America peripheral embolization coils market share in 2023.
Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the North America peripheral embolization coils market.